1 / 8

World Duchenne Muscular Dystrophy Drugs Market to Grow at 152.3% CAGR to 2019 Says a New Research Report

The analysts forecast global Duchenne muscular dystrophy drugs market to grow at a CAGR of 152.3% over the period 2014-2019. This report covers the present scenario and the growth prospects of the global Duchenne muscular dystrophy drugs market for the period 2015-2019.<br> Complete Report Available at http://www.sandlerresearch.org/global-duchenne-muscular-dystrophy-drugs-market-2015-2019.html<br>

andreamiller
Télécharger la présentation

World Duchenne Muscular Dystrophy Drugs Market to Grow at 152.3% CAGR to 2019 Says a New Research Report

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Published : Aug-2015 No. of Pages : 67 (Single User License of the Report is Available at US $2500) Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 Reach us at Call: + 1 888 391 5441 | Email: sales@sandlerresearch.org Visit: http://www.sandlerresearch.org

  2. “The analysts forecast global Duchenne muscular dystrophy drugs market to grow at a CAGR of 152.3% over the period 2014-2019. The bones also develop peculiarly, causing skeletal deformities in the patient. Occurrences of pseudo-hypertrophy, cardiomyopathy, and breathing complications are some of the other symptoms of this condition.” Special Offer on Technavio/Infiniti Reports Buy 3 reports at the Cost of 2 (Lowest Priced Report will be free)/ Buy 3 Reports of the Same Price for the Cost of 2. Buy 4 or more Reports and get 50% flat discount on the total price. [IMP Note: This Offer Only Valid Via Email To sales@sandlerresearch.org OR Call +1-888-391-5441] Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 CAGR Forecast Purchase a Copy at http://www.sandlerresearch.org/purchase?rname=42294

  3. This report covers the present scenario and the growth prospects of the global Duchenne muscular dystrophy drugs market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various off-label and branded drugs and the expected launch of drug candidates intended to be used in the treatment of Duchenne muscular dystrophy. • The report, Global Duchenne Muscular Dystrophy Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global Duchenne muscular dystrophy drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 Report Covers Inquire Further on the Report at http://www.sandlerresearch.org/inquire-before-buying?rname=42294

  4. Duchenne muscular dystrophy is an X-linked disease, which generally affects the male population. It is characterized by progressive muscle degeneration and weakness. The disease is caused due to mutations in the dystrophin gene, which result in the lack of production of dystrophin (a protein essential for maintaining healthy muscle function) in individuals. The lack of dystrophin weakens muscle function, causes loss of ambulation, harms the respiratory and cardiac function, and ultimately leads to death. The main symptoms of this condition appears in childhood and includes delay of motor functions; progressive muscle weakness; muscle contractures in legs; and muscle weakness in arms, neck, and more severely in the lower half of the body. The bones also develop peculiarly, causing skeletal deformities in the patient. Occurrences of pseudo-hypertrophy, cardiomyopathy, and breathing complications are some of the other symptoms of this condition. Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 About Duchenne Muscular Dystrophy Drugs Read Full Report at http://www.sandlerresearch.org/global-duchenne-muscular-dystrophy-drugs-market-2015-2019.html

  5. Market Driver Significant unmet medical need • Market Challenge High cost • Market Trend Focus on novel targets Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 Market Key Components Discount on the Report at http://www.sandlerresearch.org/discount?rname=42294

  6. BioMarin Pharmaceutical, Eli Lilly, PTC Therapeutics, Santhera Pharmaceuticals and Sarepta Therapeutics Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 Key Vendors Other Prominent Vendors • AcceleronPharma • Akashi Therapeutics • AsklepiosBioPharmaceuticals • Bristol-Myers Squibb • Capricor Therapeutics • Catabasis Pharmaceuticals • Janssen Pharmaceuticals • Lexicon Pharmaceuticals Order By Fax: http://www.sandlerresearch.org/order-by-fax?rname=42294

  7. What will the market size be in 2019 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors? NOTE: This Report Is NOT Free Of Charge. Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 Key Questions Answered in this Report Call: + 1 888 391 5441 | Email: sales@sandlerresearch.org

  8. About US: Sandlerresearch.org (http://www.sandlerresearch.org/ ) is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business. Mail US at: sales@sandlerresearch.org Phone: + 1 888 391 5441 Find US:

More Related